With the analysis among 1,101 patents, we discovered top 188 key players by total patent application. Bristol Myers Squibb Co., F. Hoffmann-La Roche Ltd., Jiangsu Hengrui Pharmaceuticals Co., Ltd. are dominant in this area. They take 18.44% of the total patent filing.
New York, United States
Patent: 98
F. Hoffmann-La Roche Ltd.
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Jiangsu Sheng, China
Patent: 37
Shanghai Hengrui Pharmaceutical Co., Ltd.
Shanghai Shi, China
Patent: 35
Basel-Stadt, Switzerland
Patent: 31
Biokine Therapeutics Ltd.
Illinois, United States
Patent: 26
Washington, United States
Patent: 26
Tokyo-to, Japan
Patent: 24
With the analysis among 46 patents, we discovered top 9 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, Lyvgen Biopharma Co., Ltd, Hibercell, Inc. are active in this area.
Institut National de la Santé et de la Recherche Médicale
Lyvgen Biopharma Co., Ltd
Shanghai Shi, China
Patent: 12
New York, United States
Patent: 6
Eucure (Beijing) Biopharma Co., Ltd.
Beijing Shi, China
Patent: 3
Washington, United States
Patent: 2
North Carolina, United States
Patent: 1
Jiangsu Sheng, China
Patent: 1
Hangzhou Biolynx Technology Co. Ltd.
Zhejiang Sheng, China
Patent: 1
With the analysis among related 781 patents applied in the last 5 years. We discover 172 most active companies in this area. The fast-growing Bristol Myers Squibb Co., F. Hoffmann-La Roche Ltd., Jiangsu Hengrui Pharmaceuticals Co., Ltd. take 18.95% of patent filing during this period.
New York, United States
Patent: 57
F. Hoffmann-La Roche Ltd.
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Jiangsu Sheng, China
Patent: 38
Shanghai Hengrui Pharmaceutical Co., Ltd.
Shanghai Shi, China
Patent: 36
Biokine Therapeutics Ltd.
Tokyo-to, Japan
Patent: 21
ZURICH, Switzerland
Patent: 17
California, United States
Patent: 17
Yeda Research & Development Co. Ltd.
With the analysis among related 781 patents in last 5 years, we discover 120 new entrants. Jiangsu Hengrui Pharmaceuticals Co., Ltd., Shanghai Hengrui Pharmaceutical Co., Ltd., Molecular Partners AG are the most active new entrants in this area.
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Jiangsu Sheng, China
Patent: 38
Shanghai Hengrui Pharmaceutical Co., Ltd.
Shanghai Shi, China
Patent: 36
ZURICH, Switzerland
Patent: 17
California, United States
Patent: 17
Beijing Mabworks Biotech Co., Ltd.
Beijing Shi, China
Patent: 14
Lyvgen Biopharma Co., Ltd
Shanghai Shi, China
Patent: 12
Utrecht, Netherlands
Patent: 11
Universite Paris Est Creteil Val De Marne
New Jersey, United States
Patent: 10
With the analysis among 241 patents, we discovered top 42 universities and scientific research institutions by total patent application. Dartmouth College, Baylor College of Medicine, The Rockefeller University are dominant in this area. They take 21.99% of the total patent filing.
New Hampshire, United States
Patent: 12
Baylor College of Medicine
Texas, United States
Patent: 12
The Rockefeller University
New York, United States
Patent: 10
Universite Paris Est Creteil Val De Marne
Regents of the University of Colorado
Colorado, United States
Patent: 10
Tianjin Shi, China
Patent: 10
Texas, United States
Patent: 9
Georgia, United States
Patent: 8
Antwerpen, Belgium
Patent: 8
King Abdulaziz University